Eliyahou Et Al Harari bought $10.0M of CapsoVision (CV)
Executed Sep 18, disclosed Sep 24, 5 days later, against a two-business-day limit.
Not yet measured: the 21-session window has not closed, or the prices around it are not on record.
Eliyahou Et Al Harari (10% owner) filed 4 Form 4 reports in the trailing twelve months (4 purchases, 0 sales, 2 filed past the two-business-day deadline), most often in CapsoVision, Inc. (CV). Across 3 priced purchase filings, the average 21-session return was +2.0% from execution and +4.8% from disclosure (delay-adjusted; derived). The largest single filing was $10.0M of CV (1,757,469 sh across 2 lots, as filed), executed Sep 18.
Healthcare · CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of t…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→61,068 sh × $6.73
Exec Jul 17
Filed Jul 21 · 7:04 PM ET CVPURCHASE CapsoVision, Inc. $495K
81,300 sh × $6.09
Exec Jul 8
Filed Jul 10 · 8:17 PM ET CVPURCHASE CapsoVision, Inc. $102K
13,850 sh × $7.35
Exec Jun 26
Filed Jul 7 · 10:03 PM ET †